Anyone familiar with the cannabis industry knows how difficult it is to make money. Things are going to be even worse for people in the state-legal psychedelics industry – much worse. There are a few key reasons for this. I should note that this post is focused on the state-legal psychedelics industry (i.e., service centers)
Last week, the Oregon Health Authority (OHA) awarded a pair of psilocybin manufacturer licenses. First two! Congrats to Tori Arbrust of Satori Farms PDX, and Andres Met of Satya Therapeutics, known to many of us from the Oregon cannabis program. We should also congratulate OHA, which had aimed to issue manufacturing licenses by the end
It seems that the Oregon psilocybin program is off to a slow start. The Oregon Health Authority (OHA) did a good job meeting the Measure 109 rulemaking and development deadlines, including by opening the license application portal back on January 2. Still, a slew of factors, some of them structural, have tempered program launch. The
We’re finally ready to launch. After a two-year advisory and developmental period, the Oregon Health Authority (OHA) has adopted and released final rules to implement a first-of-its-kind, regulated psychedelics program. You can find the new rules here. OHA will also begin accepting applications for psilocybin service centers, testing labs, manufacturers and facilitators next Monday, January
Last week, we presented a psychedelics webinar entitled “How to Protect Your Psychedelics Business.” The panelists were Paul Coble, me (Griffen Thorne from our Los Angeles office), and Graham Pechenik of Calyx Law in San Francisco. In the webinar, we presented on business law and intellectual property issues that will affect new psychedelics businesses in
This is the sixth and final installment in my write-up of the proposed Oregon psilocybin program rules. This post will cover product transportation and tracking, advertising, prohibited conduct, and penalties. I’ll skip waste management. As with earlier installments in this series (linked below), this post will highlight key areas and skip or skim less prominent
Welcome to the penultimate installment in my write-up of the proposed Oregon psilocybin program rules. This post focuses on facilitators and related client matters. It does not canvass the already-adopted rules related to facilitator licensing, which we covered back in April. As with earlier installments in this series (see links below), this post will highlight
The Oregon Health Authority (OHA) released the rest of its draft psilocybin rules as predicted a few weeks back. We’ve had a minute to look at them. This post and the next few will cover some of the high points. In general, OHA did a good job implementing the Oregon Psilocybin Advisory Board’s (“Board”) recommendations
Earlier this year, Utah passed a law that will directly impact ketamine clinics. The new law is entitled “Anesthesia and sedation requirements – Unprofessional conduct – Whistleblower protection.” Ut. St. § 58-1-510. The new law is effective as of May 4, 2022, but the implementing regulations have been passed or implemented yet. We believe that
The Oregon Psilocybin Advisory Board (OPAB) was established by Measure 109 and is responsible for making recommendations to the Oregon Health Authority (OHA) for psilocybin services in Oregon. OPAB has met monthly since March of 2021, and the last monthly meeting was set for June 22, 2022. After that, OPAB will meet every two months. In a
